Hantz Financial Services’s Pacific Biosciences PACB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 2273 |
|
|
2025
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 1906 |
|
|
2024
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 1188 |
|
|
2024
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 1160 |
|
|
2024
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 1215 |
|
|
2024
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 1277 |
|
|
2023
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 1207 |
|
|
2023
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 1176 |
|
|
2023
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 1157 |
|
|
2023
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 1181 |
|
|
2022
Q4 | $0 | Hold |
4
| – | – | ﹤0.01% | 1142 |
|
|
2022
Q3 | $0 | Hold |
4
| – | – | ﹤0.01% | 1129 |
|
|
2022
Q2 | $0 | Hold |
4
| – | – | ﹤0.01% | 1100 |
|
|
2022
Q1 | $0 | Hold |
4
| – | – | ﹤0.01% | 1106 |
|
|
2021
Q4 | $0 | Buy |
+4
| New | – | ﹤0.01% | 897 |
|